Phase 1 Trial of Vaccination with Autologous Tumor Cells and Antisense Directed Against the Insulin Growth Factor Type 1 Receptor (IGF-1R AS ODN) in Patients with Recurrent Glioblastoma
Keyword(s):
Phase 1
◽
2021 ◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
1993 ◽
Vol 268
(16)
◽
pp. 11542-11547
Keyword(s):
2012 ◽
Vol 48
(16)
◽
pp. 3027-3035
◽
Keyword(s):